This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Llull, D.
Right arrow Articles by García, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Llull, D.
Right arrow Articles by García, E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2007, p. 1844-1848, Vol. 51, No. 5
0066-4804/07/$08.00+0     doi:10.1128/AAC.01428-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

In Vitro Bactericidal Activity of the Antiprotozoal Drug Miltefosine against Streptococcus pneumoniae and Other Pathogenic Streptococci{triangledown}

Daniel Llull,1 Luis Rivas,2 and Ernesto García1*

Departamento de Microbiología Molecular,1 Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas (CSIC), Ramiro de Maeztu 9, 28040 Madrid, Spain2

Received 15 November 2006/ Returned for modification 23 January 2007/ Accepted 3 March 2007

Miltefosine (hexadecylphosphocholine), the first oral drug against visceral leishmaniasis, triggered pneumococcal autolysis at concentrations higher than 2.5 µM. Bactericidal activity was also observed in cultures of other streptococci, although these failed to undergo lysis. The autolysis elicited by miltefosine can be attributed to triggering of the pneumococcal autolysin LytA.


* Corresponding author. Mailing address: Departamento de Microbiología Molecular, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain. Phone: (34) 91837-3112. Fax: (34) 91536-0432. E-mail: e.garcia{at}cib.csic.es

{triangledown} Published ahead of print on 12 March 2007.


Antimicrobial Agents and Chemotherapy, May 2007, p. 1844-1848, Vol. 51, No. 5
0066-4804/07/$08.00+0     doi:10.1128/AAC.01428-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.